Innate Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 25 shareholders own 34.32% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
12.2%	Novo Nordisk A/S	9,817,546	€25.8m	0%	no data
9.3%	AstraZeneca PLC	7,485,500	€19.7m	0%	no data
7.94%	Bpifrance Participations SA	6,389,406	€16.8m	0%	0.14%
0.99%	Caisse des Dépôts et Consignations	797,222	€2.1m	0%	no data
0.92%	Herve Brailly	739,784	€1.9m	0%	no data
0.64%	Mondher Mahjoubi	514,540	€1.4m	0%	no data
0.6%	Amundi Asset Management SAS	480,898	€1.3m	0%	no data
0.26%	Française Asset Management	209,000	€549.7k	0%	0.34%
0.24%	Sycomore Asset Management SA	193,042	€507.7k	0%	0.02%
0.23%	Eric Vivier	184,666	€485.7k	0%	no data
0.22%	Saint Olive Gestion	175,000	€460.3k	0%	0.05%
0.19%	Yannis Morel	154,775	€407.1k	0%	no data
0.1%	Optiver US LLC, Asset Management Arm	81,796	€215.1k	-63.5%	0.01%
0.091%	Gilles Brisson	73,059	€192.1k	0%	no data
0.069%	Dimensional Fund Advisors LP	55,199	€145.2k	0%	no data
0.061%	Millennium Management LLC	49,450	€130.1k	-20.1%	no data
0.058%	Morgan Stanley, Investment Banking and Brokerage Investments	47,049	€123.7k	-3.43%	no data
0.053%	Exchange Traded Concepts, LLC	42,431	€111.6k	0%	no data
0.05%	Odile Belzunce	40,356	€106.1k	0%	no data
0.031%	Irina Staatz-Granzer	25,100	€66.0k	0%	no data
0.028%	Patrick Langlois	22,141	€58.2k	0%	no data
0.026%	Odile Laurent	21,086	€55.4k	0%	no data
0.017%	Citadel Advisors LLC	13,281	€34.9k	0%	no data
0.0088%	Friedland Gestion	7,100	€18.7k	0%	0.3%
0.0079%	Envestnet Asset Management, Inc.	6,380	€16.8k	0%	no data